Further salmeterol/fluticasone MDI launched

Prescribers can now choose from seven metered-dose salmeterol/fluticasone inhalers, following the launch of Avenor.

Avenor is the latest salmeterol/fluticasone MDI to be available in the UK. | Zentiva

Avenor contains the long-acting beta agonist (LABA) salmeterol and the inhaled corticosteroid (ICS) fluticasone. It is indicated for regular treatment of asthma where use of a combination LABA/ICS is appropriate, in patients not adequately controlled with ICS and 'as needed' inhaled short-acting β2 agonist or those already adequately controlled on both ICS and LABA.

Three strengths of Avenor are available, providing a metered dose of 25 microgram salmeterol with fluticasone 50, 125 or 250 microgram (equivalent to a delivered dose of 23 microgram salmeterol with fluticasone 46, 115 or 230 microgram, respectively).

The lowest 25 microgram/50 microgram strength is licensed for use in children from the age of 4 years; the two higher strengths can be used in adults and adolescents from 12 years.

For patients who require a spacer for use with Avenor, AeroChamber Plus is the recommended device. 

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in